Posted on by

Amarin gets FDA approval for new Vascepa use, U.S. shares gain in late trading – MarketWatch

  1. Amarin gets FDA approval for new Vascepa use, U.S. shares gain in late trading  MarketWatch
  2. US approves fish oil-based drug for cutting heart risks  Yahoo Lifestyle
  3. Amarin Stock Remains Halted After FDA Approves Vascepa In Cardiovascular Risk  Investor’s Business Daily
  4. FDA approves first fish-oil drug for cutting cardiac risks  NBCNews.com
  5. FDA Approves Fish-Oil-Derived Drug for Use Preventing Heart Attacks, Strokes  The Wall Street Journal
  6. View full coverage on Google News